TIS 0.00% 0.0¢ tissue therapies limited

defer us trials until cashflow, page-21

  1. 11,875 Posts.
    i agree resourced,

    best to defer

    its also about time this company started thinking outside the square in terms of generating cashflow as well

    id rather hear about the entire batch in cold storage heading to some country for medical tourism use

    you know if you have a staph infection that cant be cured by antibiotics and your leg is coming off you can go to Georgia and get treated by bacteriophages

    here is some info

    http://www.youtube.com/watch?v=2m_8T6wDT-M

    http://en.wikipedia.org/wiki/Bacteriophage

    "Their use has continued since the end of the Cold War in Georgia and elsewhere in Eastern Europe. Globalyz Biotech is an international joint venture that commercializes bacteriophage treatment and its various applications across the globe. The company has successfully used bacteriophages in administering Phage therapy to patients suffering from bacterial infections, including: Staphylococcus (including MRSA), Streptococcus, Pseudomonas, Salmonella, skin and soft tissue, gastrointestinal, respiratory, and orthopedic infections."


 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.